Monitoring and Follow-Up

Authored by Dr Wilmot, this activity focusses on the most effective way to monitor people with diabetes, particularly focusing on the use of CGM, and when and how treatment should be adapted to reduce the risk of hypoglycemia.

Learning objectives

After taking part in this module, you will be able to:


In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and Springer Healthcare IME. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity will be certified with 0.25 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.


Transcripts are available in French, German, Italian and Spanish.


Dr Emma Wilmot

Please login to access this content


Register for a Free Account

Scroll to Top

Dr Emma Wilmot

Consultant Diabetologist, University Hospitals of Derby and Burton NHS Foundation Trust and Honorary (consultant) Assistant Professor, University of Nottingham, Nottingham, UK

Emma Wilmot’s specialist interests include Type 1 diabetes, insulin pump therapy and diabetes technology, young adults with diabetes and antenatal diabetes care.

Dr Wilmot is chair of the ABCD Diabetes Technology Network UK. In this role she leads the delivery of a program of educational events for multidisciplinary diabetes teams. She has led the development of a suite of national ‘best practice’ guides related to insulin pump therapy and is a member of the National Diabetes Audit Insulin Pump Expert Reference Group, developing the 2018 national Type 1 diabetes service level audit. Dr Wilmot has been involved in the #language matters movement which aims to improve healthcare professional communication with people with diabetes.

Dr Wilmot was awarded the University of Leicester medal for excellent PhD performance in 2013 for her PhD “Type 2 diabetes in younger adults”.


Personal fees from Abbott Diabetes Care, Dexcom, Diasend, Eli Lilly, Medtronic, Novo Nordisk, Sanofi Aventis.



  • This field is for validation purposes and should be left unchanged.

Contact us

  • This field is for validation purposes and should be left unchanged.

Sign up

* indicates required